---
title: "Cell Point (India) Ltd (CELLPOINT) — Share Price, Financials & Analysis"
symbol: "CELLPOINT"
company: "Cell Point (India) Ltd"
canonical: "https://tapetide.com/stocks/CELLPOINT"
isin: "INE0O0001013"
nse_symbol: "CELLPOINT"
sector: "Retail"
industry: "Speciality Retail"
market_cap_cr: 27.93
generated_at: "2026-09-13T19:32:58.458Z"
---

# Cell Point (India) Ltd (CELLPOINT)

Canonical page: https://tapetide.com/stocks/CELLPOINT

## Company

- **NSE Symbol:** CELLPOINT
- **ISIN:** INE0O0001013
- **Sector:** Retail
- **Industry:** Speciality Retail
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2023-06-28
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** cellpoint.biz

## About

Incorporated in 2001, Cell Point (India)
 Ltd trades in smartphones and other 
 consumer durable electronic goods[1]

## Latest Price

- **Price:** ₹14.95
- **Change:** 0 (0%)
- **Open:** ₹14.95
- **Day High:** ₹14.95
- **Day Low:** ₹14.95
- **Previous Close:** ₹14.95
- **Volume:** 1200
- **As Of:** 2026-09-11T03:51:39+00:00

## Key Fundamentals

Observed at 2026-09-11T04:36:37.440626Z.

- **Market Cap:** ₹27.93 Cr
- **Classification:** SME
- **P/E (reported):** 498.3
- **EPS (reported):** ₹0.91
- **Book Value:** ₹39.77
- **Price to Book:** 0.38
- **Dividend Yield:** 1.67%
- **ROE:** 3.05%
- **ROCE:** 10.55%
- **Debt to Equity:** 1.03
- **Revenue (yearly):** ₹367.93 Cr
- **Net Income:** ₹0.24 Cr
- **EBITDA:** ₹10.23 Cr
- **52-Week High:** ₹21.1
- **52-Week Low:** ₹11.7
- **RSI (14):** 42.25

## Tapetide Score

- **Score:** 50 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Rising
- **Percentile:** 47.7 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 31.46 | 9% |
| growth | 67.82 | 9% |
| momentum | 75.09 | 12% |
| ownership | 50 | 24% |
| quality | 50.14 | 22% |
| valuation | 63.23 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.38 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 1.10% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 90.39% | -111.18% | -129.36% |
| ebitda margin growth | -8% | 2.21% | -13.13% | -35.2% |
| net income growth | -52.63% | -89.57% | -79% | -39% |
| revenue growth | 4.01% | 12.76% | 9% | 11% |
| roce | — | -8.1% | -77.86% | 24.03% |
| roe | — | 29.79% | 12.96% | -48.31% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 149 | 147 | 158 | 163 | 154 | 171 | 177 | 191 |
| Expenses | 140 | 138 | 153 | 159 | 149 | 168 | 173 | 185 |
| Operating Profit | 9 | 9 | 5 | 4 | 5 | 3 | 4 | 6 |
| OPM % | 6 | 6 | 2.9 | 2.5 | 3 | 1.6 | 2.4 | 3.1 |
| Other Income | 1 | 1 | 2 | 0 | 1 | 3 | 0 | 0 |
| Interest | 4 | 5 | 3 | 2 | 2 | 3 | 3 | 4 |
| Depreciation | 0 | 1 | 0 | 2 | 3 | 0 | 1 | 2 |
| Profit before tax | 5 | 4 | 2 | 0 | 0 | 2 | 0 | 1 |
| Tax % | 28 | 37 | 28 | 100 | 28 | 18 | 26 | 119 |
| Net Profit | 4 | 3 | 2 | 0 | 0 | 2 | 0 | 0 |
| EPS in Rs | 34.28 | 2.07 | 0.9 | 0.01 | 0.12 | 1.09 | 0.1 | -0.07 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 270 | 219 | 260 | 286 | 310 | 309 | 368 |
| Expenses | 261 | 211 | 249 | 268 | 301 | 302 | 358 |
| Operating Profit | 9 | 8 | 11 | 18 | 9 | 7 | 10 |
| OPM % | 3.5 | 3.6 | 4.2 | 6 | 2.8 | 2.4 | 2.8 |
| Other Income | 1 | 1 | 1 | 1 | 2 | 4 | 1 |
| Interest | 6 | 6 | 8 | 9 | 6 | 5 | 6 |
| Depreciation | 2 | 1 | 1 | 1 | 2 | 3 | 3 |
| Profit before tax | 2 | 1 | 2 | 10 | 3 | 3 | 1 |
| Tax % | 33 | 46 | 32 | 32 | 38 | 20 | 94 |
| Net Profit | 2 | 1 | 2 | 7 | 2 | 2 | 0 |
| EPS in Rs | 14.06 | 6.07 | 14.5 | 4.93 | 0.9 | 1.21 | 0.03 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 28 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 1 | 1 | 1 | 14 | 19 | 19 | 19 |
| Reserves | 10 | 11 | 12 | 6 | 53 | 56 | 56 |
| Borrowings | 29 | 39 | 52 | 56 | 49 | 45 | 77 |
| Other Liabilities | 16 | 15 | 18 | 19 | 13 | 19 | 18 |
| Total Liabilities | 56 | 65 | 83 | 95 | 134 | 138 | 169 |
| Fixed Assets | 19 | 19 | 19 | 18 | 33 | 37 | 60 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 36 | 46 | 64 | 76 | 101 | 101 | 109 |
| Total Assets | 56 | 65 | 83 | 95 | 134 | 138 | 169 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | 2 | 0 | 6 | -7 | -1 | 1 |
| Cash from Investing Activity | -1 | -1 | 0 | -3 | -31 | 2 | -28 |
| Cash from Financing Activity | 1 | 0 | 5 | -1 | 39 | -7 | 26 |
| Net Cash Flow | 1 | 1 | 5 | 2 | 2 | -6 | -1 |
| Free Cash Flow | 0 | 1 | -1 | 6 | -24 | -6 | -25 |
| CFO/OP | 26 | 39 | 5 | 42 | -62 | -9 | 19 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 1 | 0 | 1 | 0 | 0 | 1 | 1 |
| Inventory Days | 31 | 50 | 63 | 70 | 75 | 86 | 78 |
| Days Payable | 19 | 19 | 21 | 18 | 12 | 19 | 16 |
| Cash Conversion Cycle | 13 | 31 | 42 | 53 | 63 | 68 | 63 |
| Working Capital Days | 7 | -2 | -10 | -8 | -2 | 12 | 17 |
| ROCE % | — | 16 | 18 | 26 | 9 | 5 | 5 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% | 73.06% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 22.23% | 23.7% | 24.59% | 24.8% | 24.74% | 24.29% | 24.39% | 24.8% | 24.24% | 24.29% | 24.19% | 24.11% |
| Others | 4.71% | 3.24% | 2.35% | 2.14% | 2.2% | 2.65% | 2.55% | 2.14% | 2.7% | 2.65% | 2.75% | 2.83% |
| No. of Shareholders | 2488 | 2460 | 2314 | 2238 | 2155 | 2072 | 1959 | 2211 | 1888 | 2072 | 1749 | 1714 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 15.56 | Sell |
| EMA (10) | 15.41 | Sell |
| SMA (20) | 15.77 | Sell |
| EMA (20) | 15.8 | Sell |
| SMA (50) | 16.49 | Sell |
| EMA (50) | 16.19 | Sell |
| SMA (100) | 16.11 | Sell |
| EMA (100) | 16.26 | Sell |
| SMA (200) | 16.32 | Sell |
| EMA (200) | 16.7 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 42.25 | Neutral |
| MACD (12,26,9) | -0.45 | Sell |
| Stochastic (14,3,3) | 34.81 | Neutral |
| ADX (14) | 22.45 | Neutral |
| Williams %R (14) | -68.89 | Neutral |
| ATR (14) | 0.76 | High Volatility |
| ROC (12) | -6.56 | Sell |
| Stoch RSI (14) | 6.71 | Buy |
| UO (7,14,28) | 41.77 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Sep - FY2025-26 annual report corrigendum adds Form AOC-2; AGM on 29 Sep 2026 includes director reappointments. | [General Updates 9 Sep - FY2025-26 annual report corrigendum adds Form AOC-2; AGM on 29 Sep 2026 includes director reappointments.](https://nsearchives.nseindia.com/corporate/CELLPOINT_09092026172026_corrigendumtoAnnualrepcellpoint25-26.pdf) |
| 9 January 2026 - Clarifies subsidiary V-Marc Defence & Aerospace (incorp. 24 Sep 2025) had nil operations, hence identical standalone and consolidated results. | [Updates 9 January 2026 - Clarifies subsidiary V-Marc Defence & Aerospace (incorp. 24 Sep 2025) had nil operations, hence identical standalone and consolidated results.](https://nsearchives.nseindia.com/corporate/Ranjan_09012026104657_VIL.pdf) |
| 8 Sep - Cell Point corrected AGM notice annexures for 29 Sep 2026 AGM; no changes to resolutions. | [Corrigendum 8 Sep - Cell Point corrected AGM notice annexures for 29 Sep 2026 AGM; no changes to resolutions.](https://nsearchives.nseindia.com/corporate/CELLPOINT_08092026125341_corrigendum_to_noticeof13AGM.pdf) |
| 6 March 2026 - Proposed Rs.100–125 Cr expansion, acquiring ~20 acres near Roorkee (Haridwar); Phase‑I completion expected Q1 FY2026–27. | [Updates 6 March 2026 - Proposed Rs.100–125 Cr expansion, acquiring ~20 acres near Roorkee (Haridwar); Phase‑I completion expected Q1 FY2026–27.](https://nsearchives.nseindia.com/corporate/Ranjan_06032026192953_VIL.pdf) |
| 6 January 2026 - SDD compliance certificate for quarter ended Dec 31, 2025; two events captured; no non-compliance. | [Structural Digital Database 6 January 2026 - SDD compliance certificate for quarter ended Dec 31, 2025; two events captured; no non-compliance.](https://nsearchives.nseindia.com/corporate/Ranjan_06012026173131_VIL.pdf) |
| 6 January 2026 - Exchange has sought clarification from V Marc India Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. … | [Clarification - Financial Results 6 January 2026 - Exchange has sought clarification from V Marc India Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. …](https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=VMARCIND&tabIndex=sme) |
| 4 February 2026 - Clarifies V-Marc Defence subsidiary (incorporated 24 Sep 2025) had no activity; standalone and consolidated results identical. | [Reply to Clarification- Financial results 4 February 2026 - Clarifies V-Marc Defence subsidiary (incorporated 24 Sep 2025) had no activity; standalone and consolidated results identical.](https://nsearchives.nseindia.com/corporate/Ranjan_06012026155456_VIL.pdf) |
| 31 March 2026 - Trading window closed from 01-Apr-2026 until 48 hours after audited results for year ended 31-Mar-2026. | [Trading Window 31 March 2026 - Trading window closed from 01-Apr-2026 until 48 hours after audited results for year ended 31-Mar-2026.](https://nsearchives.nseindia.com/corporate/CELLPOINT_31032026114222_tradewinclosure31032026.pdf) |
| 3 Sep - Cell Point India schedules 13th AGM on 29 September 2026; record date 22 September 2026. | [Shareholders meeting 3 Sep - Cell Point India schedules 13th AGM on 29 September 2026; record date 22 September 2026.](https://nsearchives.nseindia.com/corporate/CELLPOINT_03092026122223_NOTICEOF13THAGMCELLPOINT.pdf) |
| 3 Sep - Cell Point appoints scrutinizer for 13th AGM on 29 September 2026; e-voting period disclosed. | [Updates 3 Sep - Cell Point appoints scrutinizer for 13th AGM on 29 September 2026; e-voting period disclosed.](https://nsearchives.nseindia.com/corporate/CELLPOINT_03092026131201_scrutinizerappointment__1_.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31347_CELLPOINT_2025_2026_A_33588265_04092026121324.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28390_CELLPOINT_2024_2025_A_20279133_04092025115255.pdf) |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27490_VMARCIND_2024_2025_A_19082025111414.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26268_CELLPOINT_2023_2024_30092024174438.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_24994_VMARCIND_2023_2024_17082024171523.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23279_CELLPOINT_2022_2023_02092023164934_09022023170003.zip) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_22836_VMARCIND_2022_2023_21082023133716_08212023140001.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/SME_AR_20747_VMARCIND_2021_2022_19082022154611_08192022160010.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/SME_AR_19096_VMARCIND_2020_2021_01092021003250_09012021070004.zip) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/Ranjan_07112025181743_VIL.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/VMARCIND_11112024191157_VIL.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/Ranjan_12052025190900_VIL.pdf) |
| Apr 2021 | [Concall - Apr 2021](https://archives.nseindia.com/corporate/VMARCIND_22042021121908_InvestorPresentation.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:32:58.458Z.